http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111419868-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3850cfcbc794c81d6836eb5f6cbef92e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate | 2019-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74fa9862a47a776e722c04368ae7f662 |
| publicationDate | 2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111419868-A |
| titleOfInvention | Application of Lycium barbarum polysaccharide in the preparation of nerve repairing drugs or health care products |
| abstract | The invention relates to the field of medicine, in particular to the application of Lycium barbarum polysaccharide in the preparation of nerve repairing drugs or health care products, and aims to provide the application of Lycium barbarum polysaccharide in the preparation of nerve repairing drugs or health care products, the drugs or health care products have the ability to improve nerve The function of degeneration, relieving nerve damage and repairing nerve damage; it includes: the wolfberry polysaccharide is mixed with pharmaceutically acceptable auxiliary materials or health care product auxiliary materials to prepare various forms of tablets, powders, granules and pills , ointment, liquid, capsule or injection; its beneficial effects are: the drug or health care product composed of Lycium barbarum polysaccharide has the functions of relieving nerve injury, repairing nerve injury, relieving neurodegeneration and other neuroprotective effects, and the efficacy is clear and safe. It has high performance and provides a new drug choice for clinical use. |
| priorityDate | 2019-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.